Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

BOPA 2018 | a comprehensive tool for HCPs

Jasmine Martin • 12 Oct 2018

More than half of patients that undergo cancer treatment are estimated to have had at least one potential drug-drug interaction. Here, Jasmine Martin, MSc, of the University of Liverpool, Liverpool, UK, talks about the purpose of the Cancer Drug Interactions website as a tool to assist healthcare professionals in treating patients, while ensuring significant interactions are avoided. Speaking at the British Oncology Pharmacy Association (BOPA) Annual Symposium 2018, held in Birmingham, UK, Ms Martin outlines the importance of smart apps in the healthcare setting.